Cowen Financial Products LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Tarsus Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (TARS)

Filing Manager
Cowen Financial Products LLC
Reporting Manager
Cowen Financial Products LLC
Security
Tarsus Pharmaceuticals Inc. Common Stock, $0.0001 par value per share
Symbol
TARS
Shares outstanding
38,963,837 shares
Disclosed Ownership
1,909,228 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 12:22:30 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Cowen Financial Products LLC disclosed 4.9% ownership in Tarsus Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (TARS) on 31 Dec 2024."

Quick Takeaways

  • Cowen Financial Products LLC filed SCHEDULE 13G/A for Tarsus Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (TARS).
  • Disclosed ownership: 4.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2025, 12:22.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cowen Financial Products LLC 4.9% 1,909,228 1,909,228 0 /s/ John Holmes Chief Operating Officer

Sponsored